<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gene Therapy Treatment for Haemophilia</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        body {
            font-family: 'Georgia', serif;
            background-color: #fefefe;
            color: #333;
            line-height: 1.8;
            padding: 0 15px;
        }
        .container {
            max-width: 750px;
            margin: 40px auto;
            padding: 20px;
            background-color: #ffffff;
            border-radius: 10px;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            font-family: 'Merriweather', serif;
            color: #2c3e50;
            margin-bottom: 15px;
        }
        h1 {
            font-size: 2.2em;
            text-align: center;
            margin-bottom: 25px;
        }
        h2 {
            font-size: 1.5em;
            border-left: 4px solid #3498db;
            padding-left: 10px;
            margin-top: 30px;
        }
        .footer {
            margin-top: 30px;
            padding: 15px;
            background-color: #f9f9f9;
            border-top: 1px solid #ddd;
            text-align: center;
            border-radius: 0 0 10px 10px;
        }
        .tags {
            display: flex;
            flex-wrap: wrap;
            justify-content: center;
            gap: 10px;
            margin-top: 10px;
        }
        .tag {
            background-color: #e0f7fa;
            color: #00796b;
            padding: 5px 10px;
            font-size: 0.9em;
            border-radius: 20px;
            border: 1px solid #b2ebf2;
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Gene Therapy Treatment for Haemophilia</h1>
        
        <h2>Overview</h2>
        <p>Indian scientists developed a one-time gene therapy for Haemophilia A, replacing frequent Factor VIII injections. A trial at Christian Medical College, Vellore, showed patients have been free of bleeding episodes for over a year.</p>

        <h2>What is Haemophilia A?</h2>
        <p>Haemophilia A is a genetic disorder due to insufficient Factor VIII, a clotting protein. It’s inherited in an X-linked recessive pattern, predominantly affecting males. India has 40,000 to 100,000 patients, making it the second-largest population globally.</p>

        <h2>Current Treatments</h2>
        <p>Treatments are lifelong and costly, with up to ₹2.54 crore over 10 years. Gene therapy is a more cost-effective alternative.</p>

        <h2>Gene Therapy Approach</h2>
        <p>The Vellore trial uses a lentivirus vector, replacing defective genes with healthy ones to produce Factor VIII in the liver. This method is considered safer and potentially suitable for children, unlike the FDA-approved Roctavian, which uses adenovirus vectors.</p>

        <h2>Benefits of Gene Therapy</h2>
        <p>Gene therapy reduces bleeding episodes, offers long-term relief, and eliminates the need for frequent treatments. It’s a breakthrough in affordable healthcare, especially for India’s large haemophilia population.</p>

        <div class="footer">
            <h4>Tags</h4>
            <div class="tags">
                <div class="tag">Haemophilia A</div>
                <div class="tag">Gene Therapy</div>
                <div class="tag">Factor VIII</div>
                <div class="tag">Lentivirus Vector</div>
                <div class="tag">Christian Medical College</div>
                <div class="tag">Roctavian</div>
                <div class="tag">India</div>
                <div class="tag">Blood Clotting</div>
                <div class="tag">Genetic Disorder</div>
                <div class="tag">FDA Approved</div>
                <div class="tag">Males</div>
            </div>
        </div>
    </div>
</body>
</html>
